Medtronic plc (MDT) FY2027 Q1 Statement of Cash Flows

Statement of Cash Flows

2026-04-25 to 2026-07-31

Swipe to see the full flow
Medtronic plc cash flow reconciliation, Apr 25, 2026 through Jul 31, 2026One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash. Intermediate calculation bars are lighter gray. Calculated remaining financing cash flows are purple; remaining operating and investing bundles are gray. Their underlying inflows and outflows are not separately identified. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Free cash flow is a separate comparison, not an added cash flow. Read chart description and values below for full signed amounts, including zero items.Net income → Net cash from operating activities: $1,479,000,000.00Depreciation and amortization → Operating adjustments reconciliation: $729,000,000.00Accounts receivable, net → Operating adjustments reconciliation: $224,000,000.00Deferred income taxes → Operating adjustments reconciliation: $127,000,000.00Stock-based compensation → Operating adjustments reconciliation: $125,000,000.00Provision for credit losses → Operating adjustments reconciliation: $25,000,000.00Remaining operating cash flows, net (calculated) → Operating adjustments reconciliation: $2,000,000.00Operating adjustments reconciliation → Net cash from operating activities: $314,000,000.00Operating adjustments reconciliation → Accounts payable and accrued liabilities: $531,000,000.00Operating adjustments reconciliation → Inventories: $240,000,000.00Operating adjustments reconciliation → Other operating assets and liabilities: $118,000,000.00Operating adjustments reconciliation → Other, net: $29,000,000.00Sales and maturities of investments → investing reconciliation: $2,209,000,000.00Other investing activities, net → investing reconciliation: $26,000,000.00Remaining investing cash flows, net (calculated) → investing reconciliation: $1,000,000.00investing reconciliation → Purchases of investments: $2,190,000,000.00investing reconciliation → Acquisitions, net of cash acquired: $1,162,000,000.00investing reconciliation → Additions to property, plant, and equipment: $503,000,000.00Net cash used in financing activities → financing reconciliation: $343,000,000.00Change in current debt obligations, net → financing reconciliation: $812,000,000.00Issuance of ordinary shares → financing reconciliation: $20,000,000.00Other financing activities, net → financing reconciliation: $13,000,000.00financing reconciliation → Dividends to shareholders: $921,000,000.00financing reconciliation → Repurchase of ordinary shares: $267,000,000.00Net cash used in investing activities → investing reconciliation: $1,619,000,000.00Beginning cash: Cash, cash equivalents, and restricted cash → Cash sources and uses: $1,949,000,000.00Net cash from operating activities → Cash sources and uses: $1,793,000,000.00Cash sources and uses → Exchange-rate effect: $89,000,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash: $1,691,000,000.00Cash sources and uses → Net cash used in investing activities: $1,619,000,000.00Cash sources and uses → Net cash used in financing activities: $343,000,000.00Net income: $1,479,000,000.00Net income+$1.48 BDepreciation and amortization: $729,000,000.00Depreciation & amortization+$729.00 MProvision for credit losses: $25,000,000.00Credit loss provision+$25.00 MDeferred income taxes: $127,000,000.00Deferred taxes & credits+$127.00 MStock-based compensation: $125,000,000.00Stock-based compensation+$125.00 MOther, net: -$29,000,000.00Other non-cash items−$29.00 MAccounts receivable, net: $224,000,000.00Accounts & notes receivable+$224.00 MInventories: -$240,000,000.00Inventories−$240.00 MAccounts payable and accrued liabilities: -$531,000,000.00Payables & accrued liabilities−$531.00 MOther operating assets and liabilities: -$118,000,000.00Other working capital, net−$118.00 MRemaining operating cash flows, net (calculated): $2,000,000.00Remaining operating (calculated)+$2.00 MNet cash from operating activities: $1,793,000,000.00Operating cash+$1.79 BOperating adjustments reconciliation: $1,232,000,000.00Change in current debt obligations, net: $812,000,000.00Short-term debt ≤3 months, net+$812.00 MPayments on long-term debt: $0.00Dividends to shareholders: -$921,000,000.00Common dividends paid−$921.00 MRepurchase of ordinary shares: -$267,000,000.00Common stock repurchases−$267.00 MOther financing activities, net: $13,000,000.00Other financing, net+$13.00 MIssuance of ordinary shares: $20,000,000.00Common stock issued+$20.00 MNet cash used in financing activities: -$343,000,000.00. Cash required to fund net payments.Financing cash−$343.00 Mfinancing reconciliation: $1,188,000,000.00Acquisitions, net of cash acquired: -$1,162,000,000.00Acquisitions, net of cash−$1.16 BAdditions to property, plant, and equipment: -$503,000,000.00PP&E purchases−$503.00 MPurchases of investments: -$2,190,000,000.00Investment purchases−$2.19 BSales and maturities of investments: $2,209,000,000.00Investment sales & maturities+$2.21 BOther investing activities, net: $26,000,000.00Other investing, net+$26.00 MRemaining investing cash flows, net (calculated): $1,000,000.00Remaining investing (calculated)+$1.00 MNet cash used in investing activities: -$1,619,000,000.00. Cash required to fund net payments.Investing cash−$1.62 Binvesting reconciliation: $3,855,000,000.00Cash sources and uses: $3,742,000,000.00Beginning cash: Cash, cash equivalents, and restricted cash: $1,949,000,000.00Beginning cash$1.95 BEnding cash: Cash, cash equivalents, and restricted cash: $1,691,000,000.00Ending cash$1.69 BExchange-rate effect: -$89,000,000.00FX effect−$89.00 MCASH RECONCILIATIONOperatingflowsInvestingflowsFinancingflowsFree cash flow$1.29 BOperating cash − cash spent on PP&ECash flow / Net income1.21×Operating cash flow ÷ net incomeNet cash change−$258.00 MEnding cash − beginning cash
Chart details

Medtronic plc cash flow reconciliation, Apr 25, 2026 through Jul 31, 2026

Cash flows for Apr 25, 2026 through Jul 31, 2026. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Apr 24, 2026. Ending cash: Jul 31, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Apr 24, 2026
1,949,000,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
Operating activities
1,793,000,000 US dollars. Net cash provided. The remaining amount is calculated by subtracting the other displayed items from the operating total. The filing's tagged operating lines do not add up to the operating total; this is the difference. It may combine inflows and outflows.
Net income
1,479,000,000 US dollars
Depreciation and amortization
729,000,000 US dollars
Provision for credit losses
25,000,000 US dollars
Deferred income taxes
127,000,000 US dollars
Stock-based compensation
125,000,000 US dollars
Other, net
negative 29,000,000 US dollars
Accounts receivable, net
224,000,000 US dollars
Inventories
negative 240,000,000 US dollars
Accounts payable and accrued liabilities
negative 531,000,000 US dollars
Other operating assets and liabilities
negative 118,000,000 US dollars
Remaining operating cash flows, net (calculated)
2,000,000 US dollars
Investing activities
negative 1,619,000,000 US dollars. Net cash used. The remaining amount is calculated by subtracting the other displayed items from the investing total. The filing's tagged investing lines do not add up to the investing total; this is the difference. It may combine inflows and outflows.
Acquisitions, net of cash acquired
negative 1,162,000,000 US dollars
Additions to property, plant, and equipment
negative 503,000,000 US dollars
Purchases of investments
negative 2,190,000,000 US dollars
Sales and maturities of investments
2,209,000,000 US dollars
Other investing activities, net
26,000,000 US dollars
Remaining investing cash flows, net (calculated)
1,000,000 US dollars
Financing activities
negative 343,000,000 US dollars. Net cash used.
Change in current debt obligations, net
812,000,000 US dollars
Payments on long-term debt
0 US dollars
Dividends to shareholders
negative 921,000,000 US dollars
Repurchase of ordinary shares
negative 267,000,000 US dollars
Other financing activities, net
13,000,000 US dollars
Issuance of ordinary shares
20,000,000 US dollars
Operating adjustment reconciliation
1,232,000,000 US dollars. Intermediate calculation joining the displayed items and the calculated net remainder. It does not establish gross cash receipts or payments and is not an additional cash flow.
financing gross reconciliation
1,188,000,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing displayed reconciliation
3,855,000,000 US dollars. Intermediate calculation joining the displayed items and the calculated net remainder. It does not establish gross cash receipts or payments and is not an additional cash flow.
Exchange-rate effect
negative 89,000,000 US dollars
Ending cash on Jul 31, 2026
1,691,000,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
Cash sources and uses
3,742,000,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
negative 258,000,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
1.21×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.
Operating cash flow
1,793,000,000 US dollars. Operating cash flow used in the free cash flow calculation.
Cash purchases of property, plant and equipment
503,000,000 US dollars. These cash purchases are already included in investing activities above.
Free cash flow
1,290,000,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net income enters operating cash directly in the reconciliation. The adjustment junction contributes the remaining $314.00M after reconciling the other positive and negative adjustments. These connections depict an accounting reconciliation, not traced cash receipts.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
  • Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: 1,793,000,000 US dollars minus 503,000,000 US dollars equals 1,290,000,000 US dollars.
Medtronic plc (MDT) FY2027 Q1 Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!